J Biol Chem, Vol. 275, Issue 3, 2009-2018, January 21, 2000
Biochemical Analysis of Recombinant Fungal Mutanases
A NEW FAMILY OF
1,3-GLUCANASES WITH NOVEL
CARBOHYDRATE-BINDING DOMAINS*
Claus C.
Fuglsang
§,
Randy M.
Berka¶,
Jill A.
Wahleithner¶
,
Sakari
Kauppinen
,
Jeffrey R.
Shuster¶,
Grethe
Rasmussen
,
Torben
Halkier
**,
Henrik
Dalbøge
, and
Bernard
Henrissat
From the
Novo Nordisk A/S, Bagsværd
DK-2880, Denmark, ¶ Novo Nordisk Biotech, Inc., Davis, California
95616, and 
Architecture et Fonction des
Macromolécules Biologiques, CNRS-IFR1,
13402 Marseille, France
 |
ABSTRACT |
Nucleotide sequence analysis shows that
Trichoderma harzianum and Penicillium
purpurogenum
1,3-glucanases (mutanases) have homologous
primary structures (53% amino acid sequence identity), and are
composed of two distinct domains: a NH2-terminal catalytic domain and a putative COOH-terminal polysaccharide-binding
domain separated by a O-glycosylated Pro-Ser-Thr-rich
linker peptide. Each mutanase was expressed in Aspergillus
oryzae host under the transcriptional control of a strong
-amylase gene promoter. The purified recombinant mutanases show a pH
optimum in the range from pH 3.5 to 4.5 and a temperature optimum
around 50-55 °C at pH 5.5. Also, they exhibit strong binding to
insoluble mutan with KD around 0.11 and 0.13 µM at pH 7 for the P. purpurogenum and
T. harzianum mutanases, respectively. Partial hydrolysis
showed that the COOH-terminal domain of the T. harzianum mutanase binds to mutan. The catalytic domains and the
binding domains were assigned to a new family of glycoside hydrolases
and to a new family of carbohydrate-binding domains, respectively.
 |
INTRODUCTION |
Extracellular polysaccharides produced by microbial flora in the
human oral cavity are believed to play an important role in the
adherence and proliferation of bacterial aggregates on the surface of
teeth (1). Consequently, these polysaccharides might have significance
in the development of tartar, plaque, and possibly dental carries (2).
Mutan is a major component of exopolysaccharides produced by tooth
colonizing streptococci such as Streptococcus mutans (3).
Mutan is composed of
1,3-glucan with some
1,6-glucan (dextran)
side chains. Mutanase (
1,3-glucanase, EC 3.2.1.59) and dextranase
(
1,6-glucanase, EC 3.2.1.11) enzymes could be beneficial additives
to dentifrice preparations as it has been shown that these enzymes are
capable of removing biofilms created by oral bacteria in
vitro (4) and reducing plaque formation in vivo (5, 6).
Mutanase activity from the filamentous fungus Trichoderma
harzianum was first described by Guggenheim and Haller (7).
However, only a limited number of reports are available on the
characterization of fungal mutanases. Here we describe the cloning,
expression, and subsequent characterization of two fungal mutanases
representing a new family of fungal endoglucanases with their unique
mutan-binding domains.
 |
EXPERIMENTAL PROCEDURES |
Fungal Strains--
T. harzianum strain CBS
243.71 and Penicillium purpurogenum CBS 238.95 were used as
the sources of genomic DNA. Aspergillus oryzae JaL142 and
JaL125 (obtained from J. Lehmbeck, Novo Nordisk A/S), were alkaline
protease-deficient strains used for heterologous expression of cloned
mutanases. The A. oryzae strains show no detectable level of
background mutanase activity in the assay described.
Purification and Charcaterization of the Wild-type Mutanase
from T. harzianum--
100 g of SP234 (Novo-Nordisk A/S, batch number
PPM 3897) were dissolved in 1 liter 10 mM sodium acetate,
pH 5.2. Contaminant proteins were removed by batch adsorption on
DEAE-Sephadex, then by batch adsorption on S-Sepharose (Amersham
Pharmacia Biotech). After concentration on a Filtron concentrator
equipped with a 10-kDa cut-off membrane, the unbound material was
applied to a S-Sepharose (Amersham Pharmacia Biotech) column (180 ml,
2.6 × 33 cm) equilibrated with 10 mM sodium acetate,
pH 4.7. The mutanase was eluted with a 0-20 mM linear
gradient of NaCl in the same buffer (3 column volumes). The residual
protein was eluted with the same buffer containing 1 M
NaCl. Fractions with high mutanase activity were pooled and
concentrated. After the procedure was repeated 12 times, the pooled
fractions were concentrated and placed in 10 mM Tris-HCl,
pH 8.0. The mutanase was further purified on a HiLoad Q-Sepharose
column (50 ml, 2.6 × 10 cm) equilibrated with 10 mM
Tris-HCl, pH 8.0, and eluted with a linear gradient from 0 to 50 mM NaCl in 12 column volumes. Fractions with high mutanase
activity were pooled and concentrated in an Amicon cell equipped with a
10-kDa cut-off membrane. Finally, the mutanase preparation was dialyzed
extensively against 10 mM sodium phosphate, pH 7.0. SDS-PAGE1 gave one single
band at 75 kDa (data not shown).
Carbohydrate composition analysis was performed on lyophilized samples
which were hydrolyzed in vacuo in sealed glass tubes using
100 µl of 2 M trifluoroacetic acid for 1 h and
4 h at 100 °C. Monosaccharides were separated by high
performance anion exchange chromatography using a Dionex Carbopac PA1
column eluted with 16 mM NaOH and detected by pulsed
amperometric detection.
The mutanase mass was measured using matrix-assisted laser desorption
ionization time-of-flight mass spectrometry (MALDI-MS) (VG Analytical).
Typically 2 µl of sample were mixed with 2 µl of saturated matrix
solution (
-cyano-4-hydroxycinnamic acid in 0.1% trifluoroacetic
acid:acetonitrile (70:30)) and 2 µl of the mixture were deposited on
the target plate. After evaporation of the solvent, the samples were
introduced in the spectrometer. They were desorbed and ionized by 4-ns
laser pulses (337 nm) and subjected to an accelerating voltage of 25 kV. Ions were detected by a microchannel plate set at 1850 V.
Generation of a cDNA Probe for the T. harzianum Mutanase
Using Reverse Transcriptase PCR--
T. harzianum was
cultivated as described (8). A 2-liter sample was taken after 4 days of
growth at 30 °C, and the mycelium was collected, frozen in liquid
N2, and stored at
80 °C. First-strand cDNA was
synthesized from 5 µg of T. harzianum poly(A)+
RNA as described earlier (9). A 387-bp fragment of the T. harzianum mutanase cDNA (10) was amplified using two
mutanase-specific primers (100 pmol each): forward
(5'-ACTAAGCTTTATGTTCAAAATGAGCA-3') and reverse
(5'-ACACTCTAGAACATATGGGTTGAAGTTGT-3'), a DNA thermal cycler (Landgraf,
Germany) and 2.5 units of Taq polymerase (Perkin-Elmer Cetus). Initially, two cycles of PCR were done using a cycle profile of
denaturation at 94 °C for 1 min, annealing at 45 °C for 2 min, and extension at 72 °C for 3 min, then the annealing temperature was
increased to 55 °C and 30 additional cycles were performed. The PCR
fragment of interest was subcloned into pUC18 vector and sequenced as
described previously (9)
Construction and Screening of the T. harzianum cDNA
Library--
Total RNA was prepared from frozen, powdered mycelium of
T. harzianum by extraction with guanidinium thiocyanate
followed by ultracentrifugation through a 5.7 M CsCl
cushion (11). The poly(A)+ RNA was isolated by
oligo(dT)-cellulose affinity chromatography (12). Double-stranded
cDNA was synthesized from 5 µg of T. harzianum poly(A)+ RNA as described earlier (13), except that 25 ng
of random hexanucle-otide
primers (Life Technologies, Inc.) were included in the first strand
synthesis. A cDNA library, consisting of 1.5 × 106 independent clones was constructed in the yeast
expression vector pYES 2.0 (Invitrogen) as described (13), and screened
by colony hybridization (14) using a random-primed (15)
32P-labeled (>1 × 109 cpm/µg) mutanase
cDNA fragment as a probe. The hybridizations were carried out in
2 × SSC, 5 × Denhardt's solution (14), 0.5% (w/v) SDS,
100 µg/ml denatured salmon sperm DNA for 24 h at 65 °C
followed by washes in 2 × SSC (2 × 15 min), 2 × SSC,
0.5% SDS (15 min), 0.2 × SSC, 0.5% SDS (15 min), and finally in
2 × SSC (2 × 15 min) at 65 °C.
Cloning of P. purpurogenum Mutanase Gene--
Total cellular DNA
was isolated from P. purpurogenum cells by a previously
described method (16), and used for construction of genomic DNA
libraries in the bacteriophage
-ZipLox cloning system (Life
Technologies Inc., Gaithersburg, MD) (17). Approximately 45,000 plaques
from the library were screened by plaque hybridization (18) with a
radiolabeled T. harzianum mutanase probe fragment using
moderate stringency conditions (5 × SSPE, 35% formamide (v/v),
0.3% SDS, 200 µg/ml denatured and sheared salmon testes DNA;
hybridization temperature 45 °C. Membranes were washed once in
0.2 × SSPE with 0.1% SDS at 45 °C followed by two washes in 0.2 × SSPE (no SDS) at the same temperature.) Plaques which gave hybridization signals were purified twice on Escherichia
coli Y1090ZL cells, and the mutanase clones were subsequently
excised from the
-ZipLox vector as pZL1-derivatives (19). One such clone, designated pZL-Pp6A, was selected for further study.
DNA Sequence Analysis--
DNA sequencing was done with an
Applied Biosystems Model 373A Automated DNA Sequencer (Applied
Biosystems, Inc., Foster City, CA) using a combination of shotgun DNA
sequencing (20) and the primer walking technique with dye-terminator
chemistry (21).
Construction of T. harzianum Mutanase Expression Vector--
The
T. harzianum mutanase cDNA fragment was inserted in a
two-step cloning procedure into an A. oryzae expression
vector, pMHan37 (kindly provided by I. G. Clausen, Novo Nordisk
A/S), which contains the A. nidulans amdS gene as a
selectable marker, pUC plasmid sequences for replication in E. coli, an
-amylase gene promoter from A. oryzae, and
the A. niger glucoamylase (glaA) terminator (22).
In the first step, pMHan37 was linearizd with the restriction enzymes
EcoRI and XhoI. This fragment was ligated with
the following three segments: 1) a 618-nt fragment of the
-amylase
promoter sequence bordered by an EcoRI site at the 5' end
and a BamHI site at the 3' end; 2) linker number 1 listed below which has a BamHI site at the 5' end and a
NarI site at the 3' end. This linker includes the Met start
codon and 12 amino acids of the mutanase signal sequence; and 3) a
68-nt NarI/XhoI fragment from the
mutanase cDNA clone containing amino acids 12 to 34 of the mutanase
gene. The resulting plasmid pJW99 contains the
-amylase promoter
immediately upstream from the first 34 amino acids of the mutanase
gene, followed by the A. niger glucoamylase terminator. To
complete the expression vector the mutanase cDNA fragment was
cleaved with XhoI and SphI giving a 1790-nt
fragment encoding amino acids 35-598. This fragment was ligated with
pJW99 that had been linearized with XhoI plus
XbaI and linker number 2, yielding the vector pMT1802, which
contains the entire mutanase coding region under the transcriptional
control of the A. oryzae
-amylase promoter and A. niger glucoamylase terminator. Plasmid pMT1796 is identical to
pMT1802 except that Glu-35 of the mutanase protein has been changed to
Lys-35 by replacing the XhoI/KpnI fragment of
pMT1802 with a PCR-amplified fragment containing this mutation. This
PCR fragment was created in a two-step procedure as reported in Ref. 23
using the following primers: Primer 1 (nt 2761, 5'-CAGCGTCCACATCACGAGC,
nt 2779) and Primer 2 (nt 3306, 5'-CAAGAAGCACGTTTCTCAGAGACCG, nt 3281);
Primer 3 (nt 3281 5'-CGGTCTCTGAGAAACGTGCTTCTTC, nt 3306) and Primer 4 (nt 4276, 5'-GCCACTTCCGTTATTAGCC, nt 4257); nucleotide numbers refer to
the pMT1802 plasmid.
Expression of Recombinant T. harzianum Mutanase in A. oryzae--
The A. oryzae host strain JaL125 was
transformed using a polyethylene glycol-mediated protocol (24) and a
DNA mixture containing 0.5 µg of a plasmid encoding the gene that
confers resistance to the herbicide Basta (25) and 8.0 µg of the
expression vector pMT1796. Transformants were selected on minimal
plates containing 0.5% Basta and 50 mM urea as a nitrogen
source. Each transformant was purified twice on selection media and
conidia were harvested. Universal containers (20 ml, Nunc, catalog
number 364211) containing 10 ml of YPM (2% maltose, 1% bactopeptone
bactopeptone, and 0.5% yeast extract) were inoculated with spores from
the transformants and incubated 5 days with shaking at 30 °C.
Culture supernatants were harvested after 5 days growth and assayed for
the recombinant mutanase.
Expression of P. purpurogenum Mutanase in A. oryzae--
Two
synthetic oligonucleotide primers were designed to amplify the P. purpurogenum mutanase gene from plasmid pZL-Pp6A,
5'-cccatttaaatATGAAAGTCTCCAGTGCCTTC and
5'-cccttaattaaTTAGCTCTCTACTTGACAAGC (capital letters correspond to the sequence present in the mutanase coding region). One hundred picomoles of each primer was used in a PCR reaction containing 52 ng of
plasmid DNA, 1× Pwo polymerase buffer (Roche Molecular Biochemicals, Indianapolis, IN), 1 mM each dATP, dTTP,
dGTP, dCTP, and 2.5 units of Pwo polymerase (Roche Molecular
Biochemicals). The PCR conditions were 95 °C 3 min, 25× (95 °C 1 min, 60 °C 1 min, 72 °C 1.5 min), 72 °C 5 min. The amplified
2.2-kilobase DNA fragment was purified by gel electrophoresis and cut
with restriction endonucleases SwaI and PacI
(using conditions specified by the manufacturers). The fragment was
cloned into plasmid pBANe6 (26) that had been previously cut with
SwaI and PacI and the resultant expression
plasmid was named pJeRS35. This vector was introduced into A. oryzae host strain JaL142 using a standard protoplast transformation procedure (24) and 40 transformants were selected by
their ability to grow on COVE medium using acetamide as sole nitrogen
source. The transformants were grown in 20 ml of MY50N media (MY50N in
g/liter: Nutriose (Roquette), 62; MgSO4·7H2O, 2.0; KH2PO4, 2.0; citric acid, 4.0; yeast
extract, 8.0; urea, 2.0; trace metals, 0.5 ml; pH 6.0, and then add
CaCl2, 0.1) in shaker flasks for 3 days at 34 °C with
agitation. Mutan assay plates were prepared by blending a suspension of
1% (v/w) mutan, 1% agarose in 0.1 M sodium acetate
buffer, pH 5.5, for 20 min at 4 °C. The agarose was melted by
heating and 150-mm Petri plates were poured. After solidification,
small wells (about 40 µl equivalent volume) were punched in the
plates. To screen the transformants for ability to secrete mutanase, 35 µl of centrifuged culture broth from each transformant (and one
untransformed control) were pipetted into the wells and the plates were
incubated at 37 °C. Mutanase activity in the broth samples caused
formation of clearing zones around the wells.
Preparation of Mutan--
Mutan was prepared by growing S. mutans CBS 350.71 at 37 °C, pH 6.5 (kept constant at a stirring
rate of 75 rpm in a medium comprised of the following components:
NZ-Case, 6.5 g/liter; yeast extract, 6 g/liter;
(NH4)2SO4, 20 g/liter;
K3PO4, 3 g/liter; glucose, 50 g/liter; pluronic
PE6100, 0.1%). After 35 h, sucrose was added to a final
concentration of 60 g/liter to induce glucosyltransferase. The total
fermentation time was 75 h. The supernatant from this fermentation
was centrifuged and filtered (sterile). Sucrose was added to the
supernatant to a final concentration of 5% (pH was adjusted to pH 7.0 with acetic acid) and the solution was stirred overnight at 37 °C.
The solution was filtered and the insoluble mutan harvested on a Propex
23 filter (Scapa Filtration) and washed with deionized water containing
1% sodium benzoate, pH 5 (adjusted with acetic acid). Finally, the
insoluble mutan was lyophilized and ground.
Enzyme Assays--
The production of soluble reducing sugars
released from mutan was employed as a measure of enzyme activity.
First, 0.1 ml of 5% mutan in 50 mM sodium acetate (allowed
to swell at least for 1 h), pH 5.5, was added to 0.3 ml of enzyme
sample (diluted in water) in a round-bottomed Eppendorf vial to ensure
sufficient agitation and incubated for 15 min at 40 °C while shaking
vigorously. The reaction was terminated by adding 0.1 ml of 0.4 M NaOH and the samples were centrifuged for 5 min at
14,000 × g and filtered through 0.45-µm HV-filters
(Millipore). To each filtrate (100 µl) in Eppendorf vials 750 µl of
ferricyanide reagent (0.4 g/liter K3Fe(CN)6, 20 g/liter Na2CO3) was added and incubated 15 min
at 85 °C. After allowing the samples to cool, the decrease in
absorbance at 420 nm was measured. A dilution series of glucose was
included as a standard. Proper controls (substrate and enzyme blanks)
were always included. One mutanase unit (MU) was defined as the amount of enzyme releasing 1 µmol of reducing sugar per minute at pH 5.5 and
40 °C. Temperature profiles were obtained by incubating the assay
mixture (50 mM sodium acetate, pH 5.5) at various
temperatures. The pH profiles were obtained by suspending the mutan in
50 mM buffer at various pH (glycine-HCl, pH 3-3.5; sodium
acetate, pH 4-5.5; and sodium phosphate, pH 6-7.5).
Purification of Recombinant T. harzianum Mutanase--
The
fermentation broth (700 ml) containing 15.4 MU/ml was filtered using
GF/A (Whatmann) and HV 0.45-µm (Millipore) filters and concentrated
on a Filtron concentrator equipped with a 10 kDa cut-off membrane. The
pH was adjusted to 4.7 (conductivity approximately 300 microsiemens/cm), and the broth was loaded onto an S-Sepharose column
(XK 50/22, Amersham Pharmacia Biotech) equilibrated in 10 mM sodium acetate, pH 4.7. The mutanase was eluted in a linear NaCl gradient. Fractions containing mutanase activity were pooled and concentrated on an Amicon Cell (YM10) and loaded onto a
HiLoad Q-Sepharose column (Amersham Pharmacia Biotech) equilibrated in
10 mM Tris-HCl, pH 8.0 (approximately 600 µS/cm),
in three rounds. The mutanase was eluted in a linear gradient of NaCl. Pooled fractions (according to activity/purity) were concentrated and
further purified by gel filtration on a Superdex 75 (16/60) column
(Amersham Pharmacia Biotech) in 0.1 M sodium acetate, pH 6.0.
Purification of Recombinant P. purpurogenum Mutanase--
The
fermentation broth (780 ml) containing 2.2 MU/ml was filtered (0.45 µm; HV Millipore) and mixed with 15.6 g of mutan, washed in 0.1 M sodium acetate, pH 5.5, to provide a 2% solution. The pH
was adjusted to 5.5 and the suspension was allowed to stand at 4 °C
for 1 h while stirring. The suspension was then filtered on a
sintered glass filter funnel and the mutan was washed four times with
0.1 M sodium acetate, pH 5.5 (total volume: 1110 ml), and
then six times with Milli Q-filtered deionized water (total volume,
1250 ml); after each washing step the suspension was filtered. The
mutanase eluted during the washing with water. These filtrates were
pooled, filtered (0.7 µm, Whatman), concentrated on a Filtron concentrator equipped with a 10 kDa cut-off membrane, and further concentrated to 25 ml on an Amicon cell (YM10 membrane).
Preparation of Binding Isotherms--
Equilibrium binding was
ascertained with 10 mg/ml mutan incubated at 4 °C with 0.5 MU
mutanase in 10 mM Britton-Robinson buffer, pH 7. At various
time points, samples were taken and filtered (0.45-µm HV, Millipore)
prior to measuring the activity. Binding isotherms were obtained by
incubating various concentrations of purified mutanase in a 0.2%
suspension of mutan in 0.1 M sodium phosphate, pH 7, for
1 h at 4 °C while stirring. The mutan was rinsed in buffer
prior to use. Samples were then centrifuged for 10 min at 15,000 × g and the amount of enzyme left in the supernatant determined by fluorescence spectrometry (Perkin-Elmer LS50) with excitation at 280 nm and emission at 345 nm. A fluorescence standard curve of the enzyme diluted in buffer was always included.
Alternatively, the activity was measured in the supernatant and
compared with the control. The data was fitted using the simple
Langmuir theory for adsorption to a surface: A = (Amax × Efree)/(KD + Efree), where A is the adsorbed
protein, Amax is the maximum amount of protein
which can be adsorbed to the surface, Efree is
the free protein and KD the equilibrium constant for
ES
E + S (27).
SDS-PAGE--
SDS-PAGE was done with 4-20 or 8-16% gradient
gels (Novex) according to the manufacturer's instructions.
Differential Scanning Calorimetry--
Samples for DSC were
desalted into the appropriate buffer using NAP-5 columns from Amersham
Pharmacia Biotech. Final enzyme concentrations were in the range from 2 to 3 mg/ml. Samples were scanned from 20 to 90 °C using a scan rate
of 90°/h at the MC-2 (MicroCal).
Protein Sequencing--
NH2-terminal amino acid
sequencing was done using an Applied Biosystems 473A protein sequencer
according to the manufacturer's instructions.
Isolation and Mutan Binding Activity of the COOH-terminal Domain
from the T. harzianum Mutanase--
Mutanase was incubated for
2.5 h at 30 °C with chymotrypsin (Roche Molecular Biochemicals)
in a ratio of 100:1 (mutanase:chymotrypsin, w/w) in 50 mM
NH4HCO3. The digest was investigated on
SDS-PAGE and the 41-kDa band observed was electroblotted from SDS-PAGE onto a Millipore Immobilin PSQ polyvinylidene difluoride
membrane in 10 mM CAPS, 6% methanol at 175 mA for 3 h
and subjected to NH2-terminal amino acid
sequencing, revealing a sequence of SLTIGL- corresponding to
proteolytic cleavage after amino acid residue Phe-473. A 50-µl sample
of the digest was incubated for 30 min at room temperature with 50 µl
of 2.5% mutan suspension. The sample was centrifuged for 2 min at
15,000 × g. A 30-µl volume of supernatant was then
analyzed by SDS-PAGE (Novex 4-20%). Controls without mutan were included.
 |
RESULTS |
Wild-type T. harzianum Mutanase--
Purified wild-type T. harzianum mutanase displayed a molecular mass of 75 kDa both in
SDS-PAGE and MALDI-MS. Carbohydrate composition analysis revealed only
glucose and mannose but no N-acetylglucosamine, indicating
O-glycosylation. The amount of glucose and mannose (18 and
32 mol/mol enzyme, respectively) accounts for over 8 kDa which, added
to the theoretical mass (63.8 kDa), gives a molecular mass of about 72 kDa in close agreement with the 75 kDa measured by MALDI-MS and
SDS-PAGE.
Isolation and Characterization of cDNA Clones Encoding the
Mutanase from T. harzianum--
To obtain a cDNA probe for the
T. harzianum mutanase, two oligonucleotides based on a
genomic mutanase clone from T. harzianum (10) were designed.
These primers were used to amplify a mutanase cDNA fragment from
T. harzianum first-strand cDNA employing the PCR
technique (28). Sequencing of the subcloned PCR fragment revealed a
387-bp cDNA with an open reading frame of 129 amino acids. In
addition to the primer-encoded residues, the ORF was identical to the
corresponding region in the T. harzianum mutanase amino acid
sequence (10), confirming that the PCR had specifically amplified the
desired cDNA species. Approximately 10,000 colonies from a T. harzianum cDNA library in E. coli were screened
using the mutanase-specific PCR product as a probe. This yielded 12 positive clones with inserts ranging from 0.8 to 2.0 kilobase. These
were further analyzed by sequencing the ends of the cDNAs with
forward and reverse pYES polylinker primers, and determining the
nucleotide sequence of the longest cDNA from both strands with
synthetic oligonucleotide primers. The nucleotide sequence and the
deduced amino acid sequence of the mutanase cDNA from T. harzianum are presented in Fig. 1.
The 2062-bp cDNA clone contains a 1905-bp open reading frame
initiating with an ATG codon at nucleotide position 29 and terminating
with a TAG stop codon at nucleotide position 1931, thus predicting a
634-residue polypeptide. The open reading frame is preceded by a 28-bp
5'-noncoding region and followed by a 119-bp 3'-noncoding region and a
poly(A) tail.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
The nucleotide sequence and the deduced amino
acid sequence of the 1,3-glucanase (mutanase)
cDNA from T. harzianum. The signal peptide
and propeptide region are underlined, and the
NH2-terminal residues determined from the purified,
recombinant T. harzianum mutanase are indicated by
double underlines. The putative linker region (rich in Ser,
Pro, and Thr) flanked by Cys residues at positions 484 and 553 is
highlighted in gray. Noncoding sequences are in
lowercase letters. This sequence has been deposited in the
GeneseqTM data base with the accession number V12368.
|
|
Cloning of P. purpurogenum Mutanase--
Southern blotting
experiments indicated that the T. harzianum mutanase
cDNA could be used as a probe to identify mutanase gene-specific
fragments in P. purpurogenum genomic DNA (data not shown).
Consequently, a genomic library was constructed from P. purpurogenum cellular DNA using the bacteriophage vector
- ZipLox. Approximately 45,000 plaques from this library were
screened by hybridization using a segment of the T. harzianum mutanase cDNA as the probe. Eighteen positive clones
which hybridized strongly to the probe were picked and 10 were
plaque-purified (18) and excised from the
cloning vector using the
in vivo excision protocol (19). Preliminary restriction
mapping on one of the pZL1-mutanase clones (designated pZL-Pp6A)
revealed that the region which hybridized to the T. harzianum mutanase cDNA was localized near one end of a
3.6-kilobase genomic DNA insert (not shown). DNA sequencing of a
portion of this segment showed an open reading frame with clear
homology to the T. harzianum mutanase cDNA and its
deduced amino acid sequence (Fig. 2). The
positions of introns and exons within the P. purpurogenum
mutanase gene were assigned based on alignments of the deduced amino
acid sequences to the corresponding T. harzianum mutanase
gene product. On the basis of this comparison, the P. purpurogenum mutanase gene is composed of five exons (126, 532, 226, 461, and 548 bp) which are punctuated by four small introns (63, 81, 58, and 78 bp). These appear to be typical fungal introns with
respect to size and composition in that all contain consensus splice
donor and acceptor sequences as well as the consensus lariat sequence
(PuCTPuAC) near the 3' end of each intervening sequence (29).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
DNA sequence and deduced amino acid sequence
of P. purpurogenum mutanase gene. The signal
peptide and propeptide region are underlined, and the
NH2-terminal residues determined from the purified,
recombinant P. purpurogenum mutanase are indicated by
double underlines. The putative linker region (rich in Ser,
Pro, and Thr residues) flanked by Cys residues at positions 477 and 547 is highlighted in gray. Introns and noncoding regions are
indicated by lowercase letters. Consensus lariat sequences
(PuCTPuAC) with each intron are denoted by a dashed
underline. This sequence has been deposited in the
GeneseqTM data base with the accession number T89024.
|
|
Comparison of Trichoderma and Penicillium Mutanase Primary
Structures--
The signal peptide and propeptide portions of P. purpurogenum mutanase and T. harzianum mutanase share
little amino acid sequence similarity; however, the mature polypeptides
(after removal of signal and propeptides) are approximately 53%
identical. The regions of greatest identity are located in the
NH2-terminal portion (residues 42 through 491; T. harzianum numbering) and over approximately the last 70 residues
of these two proteins where 60 and 63% identity is observed,
respectively. In both mutanases the NH2-terminal and
COOH-terminal domains are separated by a Pro-Ser-Thr-rich linker
region. Remarkably, the Pro-Ser-Thr-rich region of P. purpurogenum mutanase (residues 475 through 547) is composed of
69% Pro, Ser, and Thr, and is bordered roughly by Cys residues at
positions 477 and 547. As the two mutanases appeared to have a modular
structure, sequence comparisons using the BLAST algorithm to search the
non-redundant GenBank CDS translations on the NCBI server (30) were
therefore conducted on each domain separately. BLAST searches using the NH2-terminal domains did not produce any hits with known
glycosidases, however, two ORFs of unknown function in
Schizosaccharomyces pombe (C14C4.09 and
BC646.06c, GenBank Z98596 and AL035216, respectively) were picked with
highly significant scores (E values ranging from 6 × 10
50 to 10
26) suggesting that these ORFs
encode similar glycosidases. An alignment of the sequences of the
catalytic domains of the two mutanases with the two ORFs of S. pombe is shown in Fig. 3a. BLAST
searches conducted with the COOH-terminal domains of the mutanases also failed to produce any significant hit in GenBank. Within the
COOH-terminal domains of the two mutanases, two short regions display
intriguing similarity (10 residues conserved out of 15) suggesting the
existence of an internal duplication (Fig. 3b).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
a, sequence alignment of the catalytic
domains of T. harzianum (Triha) and P. purpurogenum (Penpu) mutanases (GeneseqTM protein data base
accession numbers W44193 and W32213, respectively) with the two
homologous S. pombe ORFs of unknown function
(C14C4.09 and BC646.06c, GenBank Z98596 and AL035216,
respectively). Residues identical in 3 of the 4 sequences are printed
in white on black background. b,
alignment of the mutan-binding domains of T. harzianum
(Triha) and P. purpurogenum (Penpu) mutanases. Identical
residues are printed in white on black
background. The two regions of internal similarity are
boxed.
|
|
Heterologous Expression of T. harzianum Mutanase in A. oryzae--
The T. harzianum mutanase coding region was
amplified by PCR, and the amplicon was inserted into an
Aspergillus expression vector so that the gene was under the
control of an A. orzyae
-amylase gene promoter and an
A. niger glaA terminator. The resulting expression
construct, pMTH1802, was further modified by changing aa 35 from Glu to
Lys resulting in the presence of a dibasic (KEX2-type) processing site
at the amino terminus of the mature mutanase protein. This new
expression vector, pMT1796 (Fig.
4a), was used to transform an
A. oryzae strain, and 25 independent transformants were
isolated. Mycelia from each transformant was used to inoculate 20-ml
culture tubes containing 10 ml of YPM media and cultures were grown
with shaking for 5 days at 30 °C. SDS-PAGE analysis revealed a
dominant 85-90-kDa band indicating that these transformants were
indeed expressing the recombinant mutanase gene.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Schematic maps of the vectors pMT1796 and
pJeRS35 for the heterologous expression of T. harzianum
and P. purpurogenum mutanases in A. oryzae (not to scale).
|
|
Heterologous Expression of P. purpurogenum Mutanase--
The
P. purpurogenum mutanase coding region was amplified by PCR
using primers that created 5'- and 3'-terminal restriction sites
compatible with an Aspergillus expression vector. The
amplified DNA segment was subsequently inserted into the vector which
employed a strong A. oryzae
-amylase gene promoter. The
resulting plasmid, designated pJeRS35 (Fig. 4b), was used to
transform an A. oryzae recipient strain, and 40 transformants were isolated. Mycelia from each of the transformants
were used to inoculate shaker flask cultures that were incubated for 3 days. Using a mutan agar plate assay, 14 of the transformants showed
extracellular mutanase activity as indicated by opaque clearing zones
(the control showed no clearing zone). Broth samples that were positive
in the plate assay were subsequently analyzed by SDS-PAGE. These
transformants showed a prominent band at approximately 90 kDa.
Purification of and Molecular Properties of Recombinant
Mutanases--
Recombinant T. harzianum mutanase was
purified in a three-step procedure using cation-exchange
chromatography, anion-exchange chromatography followed by size
exclusion chromatography resulting in a yield of around 24%. The
essentially pure mutanase exhibited a molecular mass around 86 kDa
(Fig. 5a). A rather broad band was observed indicating some heterogeneity and/or heavy glycosylation. The NH2-terminal amino acid sequence was
determined by protein sequencing to be Ala-Ser-Ser- thus predicting a
calculated molecular mass of 63.8 kDa for the mature enzyme (Table
I). This observation suggests that the
first 37 amino acid residues deduced from the gene sequence function as
a secretory signal peptide and propeptide. This is supported by the
fact that the NH2 terminus of the mature mutanase is not
preceded by a typical signal peptidase cleavage site (31, Fig. 1) but
rather by a cleavage site for a monobasic processing enzyme.
Furthermore, the mutanase cDNA encodes an apparent signal sequence
of 24 amino acids, with a predicted signal peptidase cleavage site
between Ala-24 and Ala-25 in the mutanase precursor (31). A simpler
procedure for purification of the recombinant P. purpurogenum mutanase was established using the information that a
putative COOH-terminal-binding domain is present in the enzyme. The
enzyme was adsorbed to insoluble mutan and subsequently eluted in
water. This procedure resulted in a 129-fold purification and a yield
around 20%. The essentially pure mutanase had a molecular mass of
about 90 kDa (Fig. 5b). NH2-terminal
amino acid sequencing revealed the following sequence:
Ser-Thr-Ser-Asp-Arg-. Thus, the deduced amino acid sequence of the
mutanase gene product (Fig. 2) predicts an amino-terminal extension of
30 amino acids which are not present in the mature enzyme and a
molecular mass for the mature enzyme of 63.6 kDa (Table I). Based on
the rules of von Heijne (31), the first 20 amino acids likely comprise
a secretory signal peptide, and the next 10 residues probably represent a propeptide segment which is removed by a subsequent proteolytic cleavage following the dibasic Arg-Arg sequence.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
SDS-PAGE 4-20% (Novex). a,
low molecular mass standard (lane 1); purified rec. T. harzianum mutanase (lane 2). b, purified
recombinant P. purpurogenum mutanase (lane
1), low molecular mass standard (lane 2).
|
|
Characterization of the Purified Recombinant Mutanases--
The
two mutanases showed similar catalytic properties. They both exhibit
slightly acidic pH optima in the range from pH 3.5 to 5.0 and pH 3.0 to
4.5 for the T. harzianum and P. purpurogenum mutanases,
respectively. At pH 5.5 the two enzymes have specific activities of 16 and 12 MU/mg, respectively, on insoluble mutan at 40 °C. Also, the
two mutanases have virtually identical temperature optima around
50-55 °C at pH 5.5. This correlates with DSC analysis of the
thermal stability of the recombinant T. harzianum mutanase which shows a midpoint denaturation temperature (TM) around 56 °C at pH 5.5 identical to that of the wild-type enzyme.
The binding properties of the two mutanases toward insoluble mutan were
investigated at steady state conditions at pH 7 and 4 °C in order to
limit hydrolysis. The kinetics of adsorption was followed by taking
samples from the supernatant of mutanase incubated with mutan. The
equilibrium was reached within 5 min, and then no further net
adsorption was observed (data not shown). Varying concentrations of
mutanase were incubated for 1 h under the above conditions with
mutan and the amount of free mutanase was determined by fluorescence
spectroscopy (concentrations verified by activity analysis) and the
amount of bound enzyme was calculated. Thus, binding isotherms were
generated, and the data fitted using the simple Langmuir model for
adsorption to a surface (Fig. 6). Rather
strong binding was observed with desorption constants of 0.13 and 0.11 µM for the T. harzianum and P. purpurogenum mutanases, respectively (Table
II). A significant difference is observed in the maximum level of enzyme which can be adsorbed to the insoluble mutan 0.549 versus 0.244 µmol of enzyme/g of mutan for the
T. harzianum and P. purpurogenum mutanases,
respectively (Table II).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Substrate binding isotherms of purified
recombinant mutanases; 0.2% mutan in 0.1 M sodium
phosphate, pH 7, 4 °C. a, recombinant T. harzianum mutanase; b, rec. P. purpurogenum
mutanase.
|
|
In order to probe the hypothesis that the homologous
COOH-terminal domain of the two fungal mutanases constitutes
a mutant-binding domain, the T. harzianum mutanase was
subjected to limited proteolysis using chymotrypsin. The protease
treatment resulted in a 41-kDa band on SDS-PAGE (Fig.
7), which was NH2 terminally
sequenced after being electroblotted onto a polyvinylidene difluoride
membrane revealing the sequence Ser-Leu-Thr-Ile-Gly-Leu- corresponding to proteolytic cleavage between Phe-473 and Ser-474. This strongly suggests that the 41-kDa band corresponds to the linker and the COOH-terminal domain. The chymotrypsin digest of the
mutanase was then incubated with 2.5% mutan before centrifuging the
sample and loading the supernatant onto SDS-PAGE. From the SDS-PAGE
analysis (Fig. 7) it is apparent that the 41-kDa band has been adsorbed to the insoluble mutan since it is no longer present in the
supernatant.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 7.
SDS-PAGE 4-20% (Novex); 2.5% mutan + chymotrypsin digest of T. harzianum mutanase
(lane 1), low molecular mass standard (lane
2), chymotrypsin digest of T. harzianum
mutanase (lane 3).
|
|
 |
DISCUSSION |
Nucleic acid sequences encoding extracellular mutanases from the
filamentous fungi T. harzianum and P. purpurogenum were cloned and successfully expressed in A. oryzae. The primary translation products of these two DNA
sequences appear to be preproenzymes, having both
NH2-terminal signal peptides and propeptides
that are removed post-translationally. The two mutanases show deduced amino acid sequence identities of 53% overall. Further analyses of the
protein sequences reveal stronger similarity between the NH2-terminal and COOH-terminal parts
of the mature enzymes, separated by a less homologous Pro, Ser, and
Thr-rich region. Consequently, like many cellulases, glucoamylases, and
chitinases, the mature mutanases appear to be made of two distinct
domains: a NH2-terminal catalytic domain, and a putative
COOH-terminal polysaccharide-binding domain separated by a
Pro-Ser-Thr-rich linker peptide. MALDI-MS and carbohydrate analysis of
the wild-type enzyme from T. harzianum suggest that the
linker region is O-glycosylated in a manner similar to the
Ser-Thr-rich linker region of A. niger glucoamylase (32). The glycosylation is even more pronounced in the recombinant enzymes which display molecular masses of 86 and 90 kDa for the T. harzianum and P. purpurogenum mutanases, respectively.
Fungal polysaccharidases harboring a Pro-Ser-Thr-rich linker separating
the catalytic from the carbohydrate-binding domain have long been known
to undergo hyperglycosylation upon expression in yeast and other
heterologous fungal systems (33).
Experiments showing that the chymotrypsin produced fragment of the
T. harzianum mutanase adsorbs to mutan gave indirect
indication that the COOH-terminal domain of the two fungal
mutanases is responsible for binding to insoluble mutan. As a first
step in an effort to further characterize the COOH-terminal
mutan-binding domain of T. harzianum mutanase, two
expression plasmids were constructed harboring (i) an internal deletion
of the coding region encompassing residues 32-542 (i.e.
coding for the isolated COOH-terminal binding domain without any
linker) and (ii) the NH2-terminal catalytic domain only.
The transformants were tested by immunodiffusion using antibodies
raised against the whole mutanase. Whereas the isolated catalytic
domain was unaffected by preincubation with mutan, the first
transformant became negative upon preincubation with mutan (data to be
described elsewhere). The inability of the catalytic domain to bind to
mutan was verified by activity anaylsis showing that no activity could
be removed from the supernatant by preincubation with insoluble mutan.
Glycoside hydrolases and transglycosidases have been classified in a
number of distinct families based on amino acid sequence similarities
(34-36). BLAST searches (30) conducted with the NH2-terminal catalytic domains of the two mutanases
described here failed to display any similarity with known glycosidases from previously defined families. Families of glycoside hydrolases being defined with at least two related sequences (34), the two
mutanases therefore allow the definition of a new family (designated family 71). Although, sequence similarities between the mutanase catalytic domains and the described ORFs of S. pombe are
such that it is predictable that all these proteins adopt a similar fold and operate via the same catalytic mechanism using a similar catalytic machinery (37-39), the precise substrate specificity of the
S. pombe proteins cannot be reliably ascertained as it has
been shown that sequence-based families of glycosidases contain enzymes
with sometimes widely different substrate specificity (34). Finally, it
is worth mentioning that, unlike the two mutanases, none of the two
S. pombe ORFs carries a COOH-terminal extension suggesting
that the encoded proteins are made of a single domain.
Cellulases, xylanases, chitinases, and starch-degrading enzymes have
long been recognized to have a modular structure with a catalytic
domain carrying one or several ancillary modules whose function is
often binding to insoluble polysaccharides (40). The best described of
these ancillary modules are probably the cellulose-binding domains
which have been classified in several distinct families based on
sequence similarities (41, 42). The lack of sequence similarity of the
two COOH-terminal domains of the mutanases with any known
carbohydrate-binding domains together with their insoluble mutan
binding activity allows the definition of a new family of
carbohydrate-binding modules.
The pH optimum observed for the two mutanases is not exactly in
agreement with the earlier reported pH optimum around pH 6.0 for the
T. harzianum mutanase (7) but comparable to the pH optimum
obtained for the Trichoderma viride (43) and the
Penicillium funiculosum mutanases (3). For comparison, the
bacterial mutanases from Bacillus circulans (44) and
Streptomyces chartreusis (45) have slightly higher pH optima
than the two fungal mutanases but similar temperature optima. Although,
the pH in the oral cavity is around pH 6-7, the slightly acidic pH
profile of the two fungal mutanases may be of importance in the
application for plaque removal as low pH values have been observed
locally in the plaque (46).
The substrate binding constants observed for the two mutanases to
insoluble mutan are, although slightly higher, in the range of reported
binding constants for cellulase adsorption to insoluble cellulose (27).
The difference in the maximum binding capacity observed for the two
mutanases may be explained by differences in the batches of mutan used
for the experiment as these have been found to vary somewhat in
quality/purity. Alternatively, a possible explanation would be that the
T. harzianum mutanase is capable of dispersing the insoluble
mutan (in analogy to cellulose-binding domains and cellulose) to a
larger extend than the P. purpurogenum mutanase and thus
revealing a larger surface area onto which the enzyme can adsorb. The
strong adsorption of the fungal mutanases may be beneficial for their
application in dentrifice as the enzymes are expected to bind to dental
plaque and thus be retained in the oral cavity where it is supposed to
exhibit its action in removing the dental plaque.
 |
ACKNOWLEDGEMENTS |
We thank Elizabeth Golightly and Lissi Willum
Nielsen for DNA sequencing; Heidi Heinsøe and Maria Juul Holm for
skillful technical assistance; Inger Christina Aalvik and Inge Høegh
for assistance in vector construction; Birthe Ravn for cultivation of
recombinant A. oryzae strains; Kim Brown for amino acid
sequencing; Jan Lehmbeck for A. oryzae host strains and Beth
Nelson for the expression vector pBANe6.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF214480 (T. harzianum mutanase gene
sequence previously listed as GeneseqTM accession number V12368) and
AF214481 (P. purpurogenum mutanase gene sequence; previously
listed as GeneseqTM accession number V81911).
§
To whom correspondence should be addressed: Novo Nordisk A/S, Novo
Allé, Bagsværd DK-2880, Denmark. E-mail: ccf@novo.dk; Tel.:
45-4442-1406; Fax: 45-4442-2202.
Present address: Dept. of Microbiology, Dartmouth
College, Dartmouth, NH 03755.
**
Present address: ProFound-Pharmaceuticals A/S, Roennegade 2, 2100 Copenhagen, Denmark.
 |
ABBREVIATIONS |
The abbreviations used are:
PAGE, polyacrylamide
gel electrophoresis;
MALDI-MS, matrix-assisted laser desorption
ionization-mass spectrometry;
PCR, polymerase chain reaction;
bp, base pair(s);
CAPS, 3-(cyclohexylamino)propanesulfonic acid;
nt, nucleotide(s);
MU, mutanase unit;
ORF, open reading frame.
 |
REFERENCES |
| 1.
|
Hamada, S.,
and Slade, H. D.
(1980)
Microbiol. Rev.
44,
331-384[Free Full Text]
|
| 2.
|
Ginsburg, I.
(1982)
in
Microbiology
(Braude, A. I., ed)
, p. 292, W. B. Saunders Co., London
|
| 3.
|
Guggenheim, B.
(1970)
Helv. Odont. Acta
14,
89-108
|
| 4.
|
Tsuchiya, R.,
Fuglsang, C. C.,
Johansen, C.,
and Aaslyng, D.
(1998)
J. Dent. Res.
77,
2713
|
| 5.
|
Guggenheim, B.,
Regolati, B.,
Schmid, R.,
and Mühlemann, H. R.
(1980)
Caries Res.
14,
128-135[Medline]
[Order article via Infotrieve]
|
| 6.
|
Kelstrup, J.,
Holm-Pedersen, P.,
and Poulsen, S.
(1978)
Scand. J. Dent. Res.
86,
93-102[Medline]
[Order article via Infotrieve]
|
| 7.
|
Guggenheim, B.,
and Haller, R.
(1972)
J. Dent. Res.
51,
394-402[Abstract/Free Full Text]
|
| 8.
|
Draborg, H.,
Kauppinen, S.,
Dalbøge, H.,
and Christgau, S.
(1995)
Biochem. Mol. Biol. Int.
36,
781-791[Medline]
[Order article via Infotrieve]
|
| 9.
|
Siggaard-Andersen, M.,
Kauppinen, S.,
and von Wettstein-Knowles, P.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4114-4118[Abstract/Free Full Text]
|
| 10.
| Aizo, M., Otoko, S., Miki, T., Soichiro, M., Junichi, M., and Minoru,
O. (1992) Japanese Patent Application JP1992058889-A1
|
| 11.
|
Chirgwin, J. M.,
Przybyla, A. E.,
MacDonald, R. J.,
and Rutter, W. J.
(1979)
Biochemistry
18,
5294-5299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Aviv, H.,
and Leder, P.
(1972)
Proc. Natl. Acad. Sci. U. S. A.
69,
1408-1412[Abstract/Free Full Text]
|
| 13.
|
Kofod, L. V.,
Kauppinen, S.,
Christgau, S.,
Andersen, L. N.,
Heldt-Hansen, H. P.,
Dörreich, K.,
and Dalbøge, H.
(1994)
J. Biol. Chem.
269,
29182-29189[Abstract/Free Full Text]
|
| 14.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 15.
|
Feinberg, A. P.,
and Vogelstein, B.
(1983)
Anal. Biochem.
132,
6-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Berka, R. M.,
Schneider, P.,
Golightly, E. J.,
Brown, S. H.,
Madden, M.,
Brown, K. M.,
Halkier, T.,
Mondorf, K.,
and Xu, F.
(1997)
Appl. Environ. Microbiol.
63,
3151-3157[Abstract]
|
| 17.
|
Berka, R. M.,
Rey, M. W.,
Brown, K. M.,
Byun, T.,
and Klotz, A. V.
(1998)
Appl. Environ. Microbiol.
64,
4423-4427[Abstract/Free Full Text]
|
| 18.
|
Davis, R. W.,
Botstein, D.,
and Roth, J. R.
(1980)
Advanced Bacterial Genetics, a Manual for Genetic Engineering
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 19.
|
D'Alessio, J. M.,
Bebee, R.,
Hartley, J. L.,
Noon, M. C.,
and Polayes, D. (Life Technologies Inc.)
(1992)
Focus®
14,
76
|
| 20.
|
Messing, J.,
Crea, R.,
and Seeburg, P. H.
(1981)
Nucleic Acids Res.
9,
309-321[Abstract/Free Full Text]
|
| 21.
|
Giesecke, H.,
Obermaier, B.,
Domedy, H.,
and Neubert, W. J.
(1992)
J. Virol. Methods
38,
47-60[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Boel, E.,
Hjort, I.,
Svennson, B.,
Norris, F.,
Norris, K. E.,
and Fiil, N. P.
(1984)
EMBO J.
3,
1097-1102[Medline]
[Order article via Infotrieve]
|
| 23.
|
Ho, S. N.,
Hunt, H. D.,
Horton, R. M.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene (Amst.)
77,
51-59[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Christensen, T.,
Wöldike, H.,
Boel, E.,
Mortensen, S. B.,
Hjortshøj, K.,
Thim, L.,
and Hansen, M. T.
(1988)
Bio/Technology
6,
1419-1422
|
| 25.
|
Straubinger, B.,
Straubinger, E.,
Wirsel, S.,
Turgeon, G.,
and Yoder, O.
(1992)
Fungal Genet. Newslett.
39,
82-83
|
| 26.
| Brody, H., Hansen, K., Lamsa, M. H., and Yaver, D. S. (1998)
World Patent Application WO9811203
|
| 27.
|
Bothwell, M. K.,
and Walker, L. P.
(1995)
Bioresour. Technol.
53,
21-29[CrossRef]
|
| 28.
|
Frohman, M. A.,
Dush, M. K.,
and Martin, G. R.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8998-9002[Abstract/Free Full Text]
|
| 29.
|
Gurr, S. J.,
Unkles, S. E.,
and Kinghorn, J. R.
(1987)
in
Gene Structure in Eukaryotic Microbes
(Kinghorn, J. R., ed)
, pp. 93-139, IRL Press, Oxford
|
| 30.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402[Abstract/Free Full Text]
|
| 31.
|
von Heijne, G.
(1986)
Nucleic Acids Res.
14,
4683-4690[Abstract/Free Full Text]
|
| 32.
|
Coutinho, P. M.,
and Reilly, P. J.
(1994)
Protein Eng.
7,
393-400[Abstract/Free Full Text]
|
| 33.
|
Van Arsdell, J. N.,
Kwok, S.,
Schweickart, V. L.,
Ladner, M. B.,
Gelfand, D. H.,
and Innis, M. A.
(1987)
Bio/Technology
5,
60-64[CrossRef]
|
| 34.
|
Henrissat, B.
(1991)
Biochem. J.
280,
309-316
|
| 35.
|
Henrissat, B.,
and Bairoch, A.
(1993)
Biochem. J.
293,
781-788
|
| 36.
|
Henrissat, B.,
and Bairoch, A.
(1996)
Biochem. J.
316,
695-696
|
| 37.
|
Gebler, J.,
Gilkes, N. R.,
Claeyssens, M.,
Wilson, D. B.,
Béguin, P.,
Wakarchuk, W. W.,
Kilburn, D. G.,
Miller, R. C., Jr.,
Warren, R. A. J.,
and Withers, S. G.
(1992)
J. Biol. Chem.
267,
12559-12561[Abstract/Free Full Text]
|
| 38.
|
Davies, G.,
and Henrissat, B.
(1995)
Structure
3,
853-859[Medline]
[Order article via Infotrieve]
|
| 39.
|
Henrissat, B.,
and Davies, G. J.
(1997)
Curr. Opin. Struct. Biol.
7,
637-644[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Gilkes, N. R.,
Henrissat, B.,
Kilburn, D. G.,
Miller, R. C.,
and Warren, R. A. J.
(1991)
Microbiol. Rev.
55,
303-315[Abstract/Free Full Text]
|
| 41.
|
Tomme, P.,
Warren, R. A. J.,
and Gilkes, N. R.
(1995)
Adv. Microb. Physiol.
37,
1-81[Medline]
[Order article via Infotrieve]
|
| 42.
|
Warren, R. A. J.
(1996)
Annu. Rev. Microbiol.
50,
183-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Hasegawa, S.,
and Nordin, J. H.
(1969)
J. Biol. Chem.
244,
5460-5470[Abstract/Free Full Text]
|
| 44.
|
Matsuda, S.,
Kawanami, Y.,
Takeda, H.,
Ooi, T.,
and Kinoshita, S.
(1997)
J. Ferment. Bioeng.
83,
593-595[CrossRef]
|
| 45.
|
Takehara, T.,
Inoue, M.,
Morioka, T.,
and Yokogawa, K.
(1981)
J. Bacteriol.
145,
729-735[Abstract/Free Full Text]
|
| 46.
|
Oppermann, R. V.
(1979)
Scand. J. Dent. Res.
87,
302-308[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg